Gland Pharma files DRHP with SEBI for IPO

13 Jul 2020 Evaluate

Gland Pharma has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) for an Initial Public Offering (IPO) that includes fresh issue of shares worth up to Rs 1,250 crore. Apart from the fresh issue, there is an Offer for Sale (OFS) of a little over 3.4 crore shares. The shares of the company are proposed to be listed on NSE and BSE.

The funds will be utilized for working capital, capital expenditure and general corporate purposes. The book running lead managers to the issue are Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura Financial Advisory and Securities (India).

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in over 60 countries, including the US, Canada, Australia and India.

Gland Pharma Share Price

1702.45 -1.80 (-0.11%)
19-Jan-2026 10:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.85
Dr. Reddys Lab 1170.20
Cipla 1376.35
Zydus Lifesciences 864.75
Lupin 2167.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×